Yuanbao Inc. – Sponsored ADR (NASDAQ:YB – Get Free Report) shares saw unusually-strong trading volume on Monday. Approximately 42,545 shares changed hands during trading, an increase of 1% from the previous session’s volume of 42,193 shares. The stock last traded at $11.9230 and had previously closed at $12.10.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings downgraded Yuanbao from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, October 8th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Reduce” and an average price target of $21.80.
Get Our Latest Research Report on Yuanbao
Yuanbao Price Performance
Yuanbao (NASDAQ:YB – Get Free Report) last released its quarterly earnings data on Friday, September 11th. The company reported $1.26 earnings per share for the quarter. Yuanbao had a return on equity of 43.75% and a net margin of 29.91%. The business had revenue of $204.92 million for the quarter.
Institutional Inflows and Outflows
An institutional investor recently bought a new stake in Yuanbao stock. Royal Bank of Canada acquired a new position in shares of Yuanbao Inc. – Sponsored ADR (NASDAQ:YB – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 4,079 shares of the company’s stock, valued at approximately $72,000.
Yuanbao Company Profile
Yuanbao Inc (NASDAQ: YB) is a China-based insurance technology company that operates a digital platform for the distribution of insurance products. The company uses online tools and data-driven technology to connect consumers with insurance coverage and support insurance agents in serving customers.
Yuanbao’s business primarily focuses on life and health insurance products, along with other types of coverage available through its platform. Its services are designed to help users learn about insurance options, compare products, complete applications and receive policy-related support.
Further Reading
- Five stocks we like better than Yuanbao
- Tax Credit Turmoil: Why Enphase and SolarEdge Face a Tough Road
- A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?
- Could T-Mobile’s Satellite Competition Fears Create a Buying Opportunity?
- Surgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow Runway
Receive News & Ratings for Yuanbao Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yuanbao and related companies with MarketBeat.com's FREE daily email newsletter.
